• HOME
  • Introduction
  • News&Announcements
news view
Subject Developing Korea's First Precision Medicine Service, 'Dr. Answer'
Selection News Date 2018-07-17 Read 1732

Developing Korea's First Precision Medicine Service, 'Dr. Answer'


The Guro hospital started the development of the service for three areas: Rare and incurable genetic disorders in children, colorectal cancer, and dementia


Korea University Guro Hospital begins the 'AI-based precision medicine solution project' which will lead the future-oriented personalized medical services.



Supported by the Ministry of Science and ICT and the National IT Industry Promotion Agency (NIPA), the project to develop Dr. Answer, a Korean precision medicine service, will be carried out for 3 years from this year to 2020 with a budget of KRW 35.7 billion (5 billion won for 2018 alone) in order to integrate and link AI medical data and 21 develop AI medical software for 8 diseases.


'Dr. Answer,' a Korean precision medicine service, is an AI software that collects and analyzes big data on medical information including medical records, images, genomes, and lifestyles of Koreans for providing more accurate diagnosis and personalized treatment.


The focus of this project is on a total of 8 major diseases including lung cancer, colorectal cancer, prostate cancer, breast cancer, cardiac · cerebrovascular diseases, and genetic disorders. The Guro hospital participates in three areas: developmental disorders and hearing loss which are included in the rare and incurable genetic disorders in children (Prof. Eun Baik-lin of Dept. Pediatrics, and Prof. Song Jae-jun of Dept. Otorhinolaryngology-head and Neck Surgery), Colorectal cancer (Prof. Lee Sun-il of Dept. Colorectal Surgery), and Dementia (Prof. Jeong Hyun-ghang of Dept. Psychiatry), and the project director is Prof. Eun Baik-lin of Dept. Pediatrics.


With 3billion Inc., a company specializing in genome analysis, Prof. Eun Baik-lin and Prof. Song Jae-jun, who are in charge of the rare and incurable genetic disorders in children, will develop an AI-based diagnostic software which analyzes genes from pediatric patients with developmental disorders and those with hearing loss, respectively. By using AI It is to develop a technology that accurately and rapidly screens genetic diseases related to developmental disorder and hearing loss. Ultimately, the goal is to effectively diagnose/cure developmental disorder and hearing loss and develop medicines for them by introducing cost-efficient genome screening in hospital.


In addition, Prof. Lee Sun-il, who is in charge of colorectal cancer, has carried out a national project for developing an AI-based multidisciplinary diagnostic system for several years. The project aims to develop a diagnosis evaluation system for precisely treating a metastatic focus of colorectal cancer patients, leading the effort to shorten the timing of realizing AI-based colorectal cancer precision treatment.


Lastly, Prof. Jeong Hyun-ghang, who is in charge of dementia, has actively participated in this project with the aim of developing an early dementia diagnosis algorithm based on brain imaging and a software that visualizes the results of magnetic resonance brain image.


For this project, which is managed by Asan Medical Center, a joint consortium is organized by 25 medical institutions that have high-quality medical data, including Korea University Guro Hospital, and 19 medical ICT · SW companies which will be in charge of creating an environment for integrating intelligent medical SW technologies and learning data.


'Dr. Answer', a Korean precision medicine service, is an intelligent service technology that utilizes medical data such as medical records, images, genome, lifestyle, etc. It is expected that Dr. Answer will lay the foundation for leading the next-generation precision medicine industry, and ultimately, contribute to improving the quality of medical service and reducing medical expenses.

Contents manager